Tolfenpyrad Derivatives Exhibit Potent Francisella -Specific Antibacterial Activity without Toxicity to Mammalian Cells In Vitro
ACS Infectious Diseases · 2024
DOI: 10.1021/acsinfecdis.4c00547 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Nimra Khalid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases & Immunology, University of Florida, Gainesville, Florida 32608, United States. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Francisella tularensis, Microbial Sensitivity Tests. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: College of Veterinary Medicine, University of Florida.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases & Immunology, University of Florida, Gainesville, Florida 32608, United States.
- Department of Large Animal Clinical Sciences, University of Florida, Gainesville, Florida 32608, United States.
- Department of Veterinary Biosciences, Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.
- Department of Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Melbourne, Victoria 3052, Australia.
- Institute for Therapeutic Innovation, University of Florida, Orlando, Florida 32827, United States.
- Emerging Pathogens Institute, University of Florida, Gainesville, Florida 32610, United States.
ORCID-Profile: Nimra Khalid, Nicole Adams, Aya C Taki, Jonathan B Baell, Robin B Gasser, Aria Eshraghi
Förderung
- College of Veterinary Medicine, University of Florida
Zitieren
APA
Khalid, N., Adams, N., Cunha, F., Taki, A. C., Le, T. G., Baell, J. B., Heine, H. S., Gasser, R. B., & Eshraghi, A. (2024). Tolfenpyrad Derivatives Exhibit Potent Francisella -Specific Antibacterial Activity without Toxicity to Mammalian Cells In Vitro. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00547
Vancouver
Khalid N, Adams N, Cunha F, Taki AC, Le TG, Baell JB, et al. Tolfenpyrad Derivatives Exhibit Potent Francisella -Specific Antibacterial Activity without Toxicity to Mammalian Cells In Vitro. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00547
BibTeX
@article{Khalid2024,
author = {Khalid, Nimra and Adams, Nicole and Cunha, Federico and Taki, Aya C and Le, Thuy G and Baell, Jonathan B and Heine, Henry S and Gasser, Robin B and Eshraghi, Aria},
title = {Tolfenpyrad Derivatives Exhibit Potent Francisella -Specific Antibacterial Activity without Toxicity to Mammalian Cells In Vitro},
journal = {ACS Infectious Diseases},
year = {2024},
doi = {10.1021/acsinfecdis.4c00547}
}
EUVIMED